Supportive care for patients with pancreatic adenocarcinoma: Symptom control and nutrition

Hematology/Oncology Clinics of North America

Volumn 16, Issue 1, 2002, Pages 105-121

  Ellison, Neil M ^a   Chevlen, Eric ^a   Still, Christopher D ^a   Dubagunta, Srinivastan ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; APPETITE STIMULANT; BACLOFEN; BISACODYL; CODEINE; DESIPRAMINE; DIPHENHYDRAMINE; FENTANYL; FLUOXETINE; HALOPERIDOL; HYDROMORPHONE; LEVORPHANOL; MEGESTROL ACETATE; METHADONE; METHYLPHENIDATE; METOCLOPRAMIDE; MORPHINE; NARCOTIC ANALGESIC AGENT; OPIATE; OXYCODONE; PAROXETINE; PEMOLINE; PETHIDINE; PSYCHOSTIMULANT AGENT; SCOPOLAMINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ANALGESIA; ANOREXIA; CACHEXIA; CANCER PAIN; CANCER PALLIATIVE THERAPY; CONSTIPATION; DEPRESSION; DRUG INDUCED DISEASE; ENTERIC FEEDING; HALLUCINATION; HUMAN; HYPERALIMENTATION; MALNUTRITION; MENTAL DISEASE; MYOCLONUS; NAUSEA; NERVE BLOCK; NEUROLYSIS; PAIN; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PRIORITY JOURNAL; PRURITUS; REVIEW; SPLANCHNIC NERVE; TOTAL PARENTERAL NUTRITION; VOMITING;

ADENOCARCINOMA; ANALGESICS; ANTIDEPRESSIVE AGENTS; AUTONOMIC DENERVATION; CACHEXIA; COMBINED MODALITY THERAPY; DEPRESSION; FEEDING METHODS; FISH OILS; HUMANS; NUTRITION DISORDERS; NUTRITIONAL SUPPORT; PAIN; PALLIATIVE CARE; PANCREATIC NEOPLASMS; SPLANCHNIC NERVES; STENTS;

EID: 0036259066     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(01)00006-5     Document Type: Review

References (89)

1. Paraplegia following intraoperative celiac plexus injection
2. Pain management of pancreatic cancer
3. Nutrition support
4. The effects of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer
5. Fish oil-enriched nutritional supplement attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer
6. Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract
7. Functional and chemical anatomy of the afferent vagal system
8. Assessing and managing depression in the terminally ill patient
9. Interaction of pancreatic ductal carcinoma with nerves leads to nerve damage
10. Applied anatomy relevant to pain
11. Effects of artificial nutrition on the nutritional status of cancer patients
12. Immune and nutritional effects of early enteral nutrition after major abdominal operations
13. Total parenteral nutrition in the cancer patient
14. A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy
15. Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region
16. Ultrasound-guided alcoholization of celiac plexus for pain control in oncology
17. Carcinoma and other tumors of the pancreas
18. Hypothesis: Dietary management improves survival from nutritionally linked cancers based on analysis of representative cases
19. The management of cancer pain
20. Treatment of "obstructive" pain by endoscopic drainage in patients with pancreatic head carcinoma
21. The prevalence of psychiatric disorders among cancer patients
22. Prognostic effects of weight loss prior to chemotherapy in cancer patients
23. Neurolytic celiac plexus block for treatment of cancer pain: A meta-analysis
24. Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer
25. Effects of EPA and other fatty acids on growth in vitro of human pancreatic cell lines
26. Retrocrural splanchnic nerve alcohol neurolysis with a CT-guided anterior transaortic approach
27. Computer tomography guided neurolytic celiac plexus block with alcohol complicated by superior mesenteric venous thrombosis
28. Evaluation of pancreatic proteolytic enzyme treatment of adenocarcinoma of pancreas, with nutrition and detoxification support
29. Psychopathology of pancreatic cancer: Psychobiologic probe
30. Cancer statistics, 2000
31. Do early symptoms of pancreatic cancer exist that can allow an earlier diagnosis?
32. A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancies
33. MR-guided celiac plexus block
34. Gastroparesis after celiac plexus block
35. Bilateral thoracoscopic splanchnicectomy: Effects on pancreatic pain and function
36. Celiac block for the treatment of pancreatic pain
37. In the public eye: News and features. US Cancer Institute funds trial of complementary therapy
38. Comparison between celiac plexus block and morphine treatment on quality of life in patients with pancreatic cancer pain
39. Pain as a predictor of outcome in patients with operable pancreatic carcinoma
40. Pain and depression in patients with newly diagnosed pancreas cancer
41. Enteral feeding in critical care, gastrointestinal diseases, and cancer
42. Video-assisted thoracoscopic sympathectomy-splanchnicectomy for pancreatic cancer pain
43. A case of reversible paraparesis following celiac plexus block
44. Thoracoscopic splanchnicectomy for control of intractable pain due to advanced pancreatic cancer
45. Thoracoscopic splanchnicectomy for control of intractable pain in pancreatic cancer
46. Pharmacologic treatment of cancer pain
47. Chemical splanchnicectomy in patients with unresectable pancreatic cancer: A prospective randomized trial
48. Randomized comparison megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia
49. Depression and the cancer patient
50. Intravenous phenotolamine mesylate alleviates the pain of pancreatic carcinoma
51. Advances in cancer pain management
52. Quality-of-life, nutritional status and gastrointestinal hormone profile following Whipple procedure
53. Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedure
54. Celiac plexus block: A reappraisal
55. Preoperative parenteral feeding in patients with gastrointestinal carcinoma
56. Indications and effects of preoperative parenteral nutrition
57. Expandable metallic prostheses for malignant obstruction of gastric outlet and proximal small bowel
58. Prognosis of advanced pancreatic cancer with reference to calorie intake
59. Abdominal pain in patients with resectable pancreatic cancer with reference to clinicopathologic findings
60. Pharmacologic management of anorexia/cachexia
61. Depression in patients with pancreatic carcinoma
62. Perioperative Total parenteral nutrition in surgical patients
63. Thoracoscopic splanchnicectomy for pain relief in unresectable pancreatic cancer
64. Prospective randomized double-blind trial of neurolytic coeliac plexus block in patients with pancreatic cancer
65. The Pancreatic Cancer Task Force: Staging of cancer of pancreas
66. Methylprednisolone as an appetite stimulant in patients with cancer
67. A prospective randomized study of adjuvant parenteral nutrition in the treatment of diffuse lymphoma: Effect on drug tolerance
68. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct
69. Mechanism of inhibition of a tumor lipid-mobilizing factor by cicosapentaenoic acid
70. Back pain in patients with ductal pancreatic cancer: Its impact on resectability and prognosis after resection
71. Thoracoscopic bilateral splanchnicotomy for pain control in unresectablc pancreatic cancer
72. Efficacy of neurolytic celiac plexus block in varying locations of pancreatic cancer: Influence on pain relief
73. Thoracoscopic splanchnicectomy for pain control in patients with unresectable carcinoma of the pancreas
74. Health-related quality of life evaluations of gastric and pancreatic cancer
75. Clinical evaluation of transhiatal bilateral splanchnicotomy for patients with intractable supramesenteric pain
76. Surgical palliation of pancreatic cancer, the UCLA experience
77. Randomized trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice
78. Pancreatic duct stents for "obstructive type" pain in pancreatic malignancy
79. Narcotic analgesic effects on the sphincter of Oddi: A review of the data and therapeutic implications in treating pancreatitis
80. Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancer
81. Changes in nutritional status associated with unresectable pancreatic cancer
82. Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor
83. Pancreatic cancer: The greatest oncological challenge
84. Transient paraplegia following alcohol celiac plexus block
85. Neuronal plasticity: Increasing the gain in pain
86. Nervous symptoms as early manifestations of carcinoma of the pancreas
87. Clinical outcome of the use of enteral stents for palliation of patients with malignant upper Gobstruction
88. Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer